Proxy Results Form 8 K

Item 5.07. Submission of Matters to a Vote of Security Holders.

The 2024 Annual Meeting of Shareholders of BioNexus Gene Lab Corp. (the "Company") was held on Friday, October 4, 2024 ("Annual Meeting"). The voting results on the five (5) proposals considered and voted on at the Annual Meeting, all of which were described in the Company's proxy statement filed with the Securities and Exchange Commission on September 16, 2024, were as follows:

Proposal 1. Re-election of Directors

The five (5) director nominees for election to the Company's Board of Directors were elected to serve until the 2025 annual meeting of shareholders. The voting results were as follows:

Director Name		FOR			AGAINST			ABSTAIN			UNCAST
Su-Leng Tan Lee			4,128,618				6,346,661				1,928				7,490,456
Koon Wai Wong			10,458,424				17,107				1,257				7,490,456
Wei Foong Lim			9,649,633				321,295				505,860				7,490,456
Muhammad Azrul bin Abdul Hamid			4,119,842				6,355,920				1,217				7,490,456
Chee Keong Yap			4,124,636				6,350,995				1,157				7,490,456

Proposal 2. Re-appointment of Auditor

To re-appoint JP Centurion & Partners PLT in Kuala Lumpur, Malaysia, as auditor of the Company to hold office from the conclusion of the Annual Meeting until the conclusion of the annual meeting of the Company to be held in 2025, and to approve the discretion of the Board to determine the remuneration of the same. The proposal was approved. The voting results were as follows:

Voting Results		FOR			AGAINST			ABSTAIN			UNCAST
Votes Cast			10,720,634				17,334				30				7,229,665

Proposal 3. Approval of the 2024 Stock Incentive Plan

The proposal was not approved (see Item 8.01 Other Matters below). The voting results were as follows:

Voting Results		FOR			AGAINST			ABSTAIN			UNCAST
Votes Cast			4,094,117				6,382,176				495				7,490,875

2

Proposal 4. Approval of a Reverse Stock Split Proposal

Approval of an amendment to our Amended and Restated Certificate of Incorporation to effect a reverse stock split of our outstanding shares of common stock, no par value, at a ratio ranging from one-for-two (1:2) to one-for-ten (1:10), with the exact ratio to be set within that range at the discretion of our Board of Directors without further approval or authorization of our stockholders. The proposal was not approved (see Item 8.01 Other Matters below). The voting results were as follows:

Voting Results		FOR			AGAINST			ABSTAIN			UNCAST
Votes Cast			4,371,573				6,378,201				1				7,217,888

Proposal 5. Approval of an Adjournment of the Annual Meeting

Approval of an adjournment of the Annual Meeting if necessary to solicit additional proxies if there are not sufficient votes in favor of Proposal No. 1 (the "Adjournment Proposal"). The proposal was not approved. The voting results were as follows:

Voting Results		FOR			AGAINST			ABSTAIN			UNCAST
Votes Cast			4,387,017				6,362,466				292				7,217,888

Public link

Please use the above public link if you want to share this noodl on another website.